44 completed. 44 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 44 | Completed 44 |
Follow Hemostatic Disorders: new trials by email Literature Review of Hemostatic Disorders trials Research Report on Hemostatic Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prevention of Cefoperazone-induced Coagulopathy Vitamin K - Antibiotic Side Effect | Phase 4 | Completed | Helwan University | 56 | 2023-02-25 | 2023-10-10 |
| Alternative Dosing Scheme of Pomalidomide 4 mg Every Other Day Versus Pomalidomide 2 mg and 4 mg Every Day; the POMAlternative Study Pomalidomide 4 mg every day in cycle 1, Pomalidomide 4 mg every other day in cycle 2, Pomalidomide 2 mg every day in cycle 2 - Multiple Myeloma in Relapse, Multiple Myeloma | Phase 4 | Completed | Amsterdam UMC, location VUmc | 12 | 2022-12-01 | 2025-04-22 |
| Home Based Daratumumab Administration for Patients With Multiple Myeloma Daratumumab and Hyaluronidase-fihj, Questionnaire Administration, Quality-of-Life Assessment - Plasma Cell Myeloma | Phase 4 | Completed | Thomas Jefferson University | 20 | 2022-11-08 | 2025-11-21 |
| Effect of Prophylactic Fibrinogen Concentrate In Scoliosis Surgery Fibrinogen Concentrate Human - Fibrinogen, Spine Deformity | Phase 4 | Completed | Brno University Hospital | 32 | 2022-06-06 | 2026-10-16 |
| The Influence of Tramadol on Platelet Function Tramadol - Drug Toxicity, Platelet Dysfunction | Phase 4 | Completed | Medical University of Graz | 33 | 2022-01-26 | 2024-01-18 |
| IV Ketorolac on Platelet Function Post-Cesarean Delivery Ketorolac Tromethamine 30 MG/ML, Placebos - Analgesia, Obstetrical, Coagulation Defect; Postpartum | Phase 4 | Completed | Beth Israel Deaconess Medical Center | 40 | 2021-01-18 | 2026-05-29 |
| Evaluate Safety and Efficacy of High-dose Melphalan HCL for Injection in MM Patients With Auto-HSC Transplantation Melphalan Hydrochloride for Injection - Multiple Myeloma | Phase 4 | Completed | CASI Pharmaceuticals (China) Co., Ltd. | 67 | 2020-07-24 | 2024-05-23 |
| A Study of Ibrutinib (PCI-32765) in Chinese Participants With Relapse or Refractory Waldenstrom's Macroglobulinemia (WM) Ibrutinib - Waldenstrom Macroglobulinemia | Phase 4 | Completed | Janssen Research & Development, LLC | 17 | 2019-12-18 | 2025-05-25 |
| Ixazomib, Lenalidomide, and Combination for Maintenance in NDMM Patients Ixazomib, Lenalidomide - Multiple Myeloma | Phase 4 | Completed | Peking Union Medical College Hospital | 211 | 2019-09-24 | 2024-08-01 |
| Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma Drug: Carfilzomib + Dexamethasone, Drug: Carfilzomib + Lenalidomide + Dexamethasone - Relapsed Refractory Multiple Myeloma | Phase 4 | Completed | Amgen | 101 | 2019-09-16 | 2026-05-11 |
| A Study of DARZALEX (Daratumumab) In Indian Participants With Relapsed and Refractory Multiple Myeloma, Whose Prior Therapy Included a Proteasome Inhibitor and an Immunomodulatory Agent Daratumumab - Multiple Myeloma | Phase 4 | Completed | Johnson & Johnson Private Limited | 150 | 2019-06-10 | 2025-02-03 |
| Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents Vaccination with pneumococcal conjugate vaccine (PCV13), Standard Antibacterial Prophylaxis - Multiple Myeloma, Pneumococcal Infection | Phase 4 | Completed | Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology | 36 | 2018-07-01 | 2022-08-31 |
| Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Apixaban - Venous Thromboembolism, Multiple Myeloma | Phase 4 | Completed | Gregory Piazza | 50 | 2018-02-28 | 2019-12-17 |
| NOrth American Study for the Treatment of Recurrent epIstaxis With DoxycycLine: The NOSTRIL Trial Doxycycline, Placebo - Epistaxis | Phase 4 | Completed | University of California, Los Angeles | 26 | 2017-12-18 | 2022-07-20 |
| Human Fibrinogen Concentrate in Pediatric Cardiac Surgery RiaStAP, Saline - Hypofibrinogenemia, Afibrinogenemia | Phase 4 | Completed | Nicklaus Children's Hospital f/k/a Miami Children's Hospital | 30 | 2017-06-01 | 2021-09-16 |
| Comparison of ASCT and Conventional Chemotherapy in High Risk Waldenström Macroglobulinemia autologous stem cell transplantation, conventional chemotherapy - Waldenström Macroglobulinemia | Phase 4 | Completed | Institute of Hematology & Blood Diseases Hospital, China | 70 | 2016-05-01 | 2026-02-11 |
| Prospective Effect of Intravenous Ketorolac on Opioid Use, EBL and Complications Following Cesarean Delivery Ketorolac, Placebo - Analgesia, Obstetrical, Postpartum Hemorrhage | Phase 4 | Completed | University Hospitals Cleveland Medical Center | 70 | 2016-05-01 | 2022-06-07 |
| The Comparison of RCD Versus BCD in Newly Diagnosed Waldenström Macroglobulinemia Bortezomib, Rituximab - Waldenström Macroglobulinemia | Phase 4 | Completed | Institute of Hematology & Blood Diseases Hospital, China | 35 | 2016-05-01 | 2026-02-11 |
| The Efficacy of TCD Following by TP Maintenance Therapy in Newly Diagnosed WM Thalidomide - Waldenström Macroglobulinemia | Phase 4 | Completed | Institute of Hematology & Blood Diseases Hospital, China | 44 | 2016-05-01 | 2026-02-11 |
| Early Administration of Fibrinogen in Polytraumatized Patients With Hypofibrinogenemia: a Randomized Feasibility Trial Fibrinogen concentrate - Trauma, Bleeding Disorder | Phase 4 | Completed | University of Sao Paulo General Hospital | 32 | 2015-12-01 | 2018-08-01 |
Showing 20 of 44. Sign in to see all of them.
Multiple Myeloma (22) · Waldenstrom Macroglobulinemia (5) · Pain (3) · Afibrinogenemia (2) · Agnosia (2) · Blood Loss, Surgical (2) · Bone Neoplasms (2) · Breast Neoplasms (2) · Epistaxis (2) · Lymphoma, Non-Hodgkin (2) · Pain, Postoperative (2) · Postoperative Hemorrhage (2) · Postpartum Hemorrhage (2) · Prostatic Neoplasms (2)
Hemic and Lymphatic Diseases (44) · Hemorrhagic Disorders (44) · Vascular Diseases (44) · Cardiovascular Diseases (43) · Hematologic Diseases (43) · Immune System Diseases (27) · Blood Protein Disorders (26) · Immunoproliferative Disorders (26) · Lymphoproliferative Disorders (26) · Neoplasms (26) · Neoplasms by Histologic Type (26) · Paraproteinemias (26) · Neoplasms, Plasma Cell (25) · Pathological Conditions, Signs and Symptoms (11)
Zoledronic Acid (7) · Bortezomib (4) · Fibrinogen (4) · Lenalidomide (3) · Cyclophosphamide (2) · Dexamethasone (2) · Filgrastim (2) · Ketorolac (2) · Ketorolac Tromethamine (2) · Melphalan (2) · Point-of-Care Systems (2) · Saline Solution (2) · Sodium Chloride (2) · Thalidomide (2) · daratumumab (2)
Institute of Hematology & Blood Diseases Hospital, China (3) · Novartis Pharmaceuticals (3) · PETHEMA Foundation (2) · Amgen (1) · Amsterdam UMC, location VUmc (1) · Assistance Publique - Hôpitaux de Paris (1) · Bayer (1) · Beth Israel Deaconess Medical Center (1) · Brno University Hospital (1) · CASI Pharmaceuticals (China) Co., Ltd. (1) · Centre Hospitalier Universitaire de Nice (1) · Columbia University (1) · Goethe University (1) · Gregory Piazza (1) · Helwan University (1)
United States (17) · China (6) · Spain (3) · France (2) · India (2) · United Kingdom (2) · Australia (1) · Austria (1) · Belarus (1) · Brazil (1) · Canada (1) · Czechia (1) · Denmark (1) · Egypt (1) · Finland (1)
Shuhua Yi, Doc (3) · Adam R Binder, MD (1) · Alastair Nimmo, MBChB (1) · Anatoly Uss, MD/PhD (1) · Barry R. Meisenberg, MD (1) · Bryan Cotton, MD (1) · Christian F Weber, Dr. (1) · Christopher Tirotta, MD (1) · Ian Walters, M.D. (1)
PMID 19246088, PMID 20825986, PMID 21626222, PMID 21912321, PMID 22443312, PMID 22914710, PMID 23446769, PMID 23979267, PMID 26069291, PMID 26644410, PMID 32418789, PMID 33042916, PMID 34582035, PMID 34755760, PMID 35305111, PMID 36853224, PMID 37236666, PMID 38079089, PMID 38116642, PMID 38205507, PMID 40396505, PMID 41062134
2005 (1), 2014 (1)